This week, the U.S. Department of Agriculture (USDA) confirmed that a dairy cow in California tested positive for atypical bovine spongiform encephalopathy (BSE, or “mad cow” disease). The USDA also confirmed the cow did not enter the animal feed or human food supply. The U.S. Food and Drug Administration is working with federal and state authorities to further investigate this case.
Café-Tasse Issues Allergy Alert on Undeclared Milk in Café-Tasse 45 gr. Noir (Dark) Chocolate Bar.
Café-Tasse S.A. is voluntarily recalling its 1.58 oz. Café-Tasse Noir (Dark) Belgian chocolate bar with best before date of “15 SEPT 2013” because it may contain undeclared traces of milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product.
Fatima Brothers Issues An Allert On Undeclared Sulfites In Shad Javantri (Whole Mace)
FATIMA BROTHERS, 56-05 55th Drive, Maspeth NY11378 is recalling SHAD JAVANTRI (WHOLE MACE) because it contains undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life threatening allergic reactions if they consume this product.
Read The Complete Story!
Alfa Sprouts Inc. (Springwater Sprouts) Recalls Alfalfa Sprouts And Clover Sprouts Due To Possible Health Risk
Alfa Sprouts Inc. of Honeoye Falls, NY is recalling approx. 100 lbs of Springwater Sprouts brand Organic Alfalfa Sprouts and bulk 3# Clover Sprouts because they may be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections to individuals with weakened immune systems. Although healthy individuals may suffer only short term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
Read The Complete Story!
KRISPAK INC. ISSUES RECALL DUE TO MIS-PACK, RESULTING in POTENTIAL ALLERGY ALERT on UNDECLARED MILK, WHEAT, and EGG in GFS BRAND HOSTESS CANDY MIX
Krispak, Inc. of Grand Rapids, MI is voluntarily recalling 16 cases of GFS Hostess Candy Mix 8-48 oz packages due to a potential mis-pack, resulting in undeclared allergens. A small number of cases of GFS Hostess Candy Mix were inadvertently put into GFS Chocolate Sprinkles packages.
Allergy Alert on Milk Products in Mrs. Weaver’s Pimento Spread
Reser’s Fine Foods, Inc. of Beaverton, OR is voluntarily recalling 653 cases of 7 oz. Mrs. Weaver’s Pimento Spread that may have been packaged into containers marked Ham Salad. The Ham Salad label does not list milk ingredients on the label. People who are allergic to milk products run the risk of serious reaction if they consume this product.
LA STAR SEAFOOD CO, INC. RECALLS DRY and SMOKED VOBLA FISH BECAUSE of POSSIBLE HEALTH RISK
LA Star Seafood Co. Inc., Los Angeles, CA is recalling Vobla Dry and Vobla Smoked because they have the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.
American Regent Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles
American Regent is conducting a nationwide voluntary recall to the Retail/Hospital level of the following product:
Epinephrine Injection, USP, 1:1000, 1 mL Ampules NDC #0517-1071-25 Lot #1395, Exp Date: July 2012
FDA strengthens international collaboration to ensure quality, safety of imported products
The U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D. today released the agency’s “Global Engagement Report” [INSERT HYPERLINK], detailing the many activities and strategies FDA is using to transform from a domestic to a global public health agency.
Report: FDA strengthens monitoring of post-approval drug safety
A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as to premarket drug review.